Page last updated: 2024-08-25

voriconazole and B-Cell Lymphoma

voriconazole has been researched along with B-Cell Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aleshin, M; Borok, J; Sarantopoulos, G; Worswick, S1
Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H1
Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M1

Other Studies

3 other study(ies) available for voriconazole and B-Cell Lymphoma

ArticleYear
Image Gallery: Immunocompromised patient presenting with inguinal rash: a case of Scedosporium apiospermum.
    The British journal of dermatology, 2017, Volume: 176, Issue:4

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Dermatomycoses; Dexamethasone; Drug Eruptions; Etoposide; Exanthema; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Lymphoma, B-Cell; Male; Opportunistic Infections; Scedosporium; Voriconazole

2017
[Three cases of fungemia caused by Blastoschizomyces capitatus].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult

2013
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Oct-01, Volume: 45, Issue:7

    Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole

2007